Drug profile · INN
protokylol hydrochloride
VENTAIRE
protokylol hydrochloride (VENTAIRE) is a beta-2 adrenergic receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Drug details — protokylol hydrochloride
- US status
- approved
- Class
- —
- Route
- ORAL
- Patents
- 0
- Programs
- 0
- Data quality
- 0.84
Quick answer
protokylol hydrochloride (VENTAIRE) is a beta-2 adrenergic receptor agonist. Route of administration: oral. Current US regulatory status: approved.
Key facts
Mechanism of action
Beta-2 adrenergic receptor agonist
Primary target: Beta-2 adrenergic receptor
Approval history
| Authority | Status | Date |
|---|---|---|
| FDA | approved | — |
Related & competitor drugs
Frequently asked questions
What is protokylol hydrochloride?
protokylol hydrochloride (VENTAIRE) is a beta-2 adrenergic receptor agonist. Route of administration: oral. Current US regulatory status: approved.
What is the brand name for protokylol hydrochloride?
VENTAIRE is a marketed brand name for protokylol hydrochloride. Check FDA Drugs@FDA for the current US label holder and prescribing information.
What is the US approval status of protokylol hydrochloride?
protokylol hydrochloride has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.